Literature DB >> 16189386

The biological variation of C-reactive protein in polycystic ovarian syndrome.

Li Wei Cho, Vijay Jayagopal, Eric S Kilpatrick, Stephen L Atkin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16189386     DOI： 10.1373/clinchem.2005.052753

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  7 in total

1.  Long term health consequences of polycystic ovarian syndrome: a review analysis.

Authors:  A Daniilidis; K Dinas
Journal:  Hippokratia       Date:  2009-04       Impact factor: 0.471

Review 2.  Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis.

Authors:  Héctor F Escobar-Morreale; Manuel Luque-Ramírez; Frank González
Journal:  Fertil Steril       Date:  2010-12-17       Impact factor: 7.329

3.  Disparate effects of atorvastatin compared with simvastatin on C-reactive protein concentrations in patients with type 2 diabetes.

Authors:  Thozhukat Sathyapalan; Stephen L Atkin; Eric S Kilpatrick
Journal:  Diabetes Care       Date:  2010-09       Impact factor: 19.112

4.  Repeating tests: different roles in research studies and clinical medicine.

Authors:  Paul A Monach
Journal:  Biomark Med       Date:  2012-10       Impact factor: 2.851

5.  Ameliorative effects of rutin against metabolic, biochemical and hormonal disturbances in polycystic ovary syndrome in rats.

Authors:  Sarwat Jahan; Faryal Munir; Suhail Razak; Anam Mehboob; Qurat Ul Ain; Hizb Ullah; Tayyaba Afsar; Ghazala Shaheen; Ali Almajwal
Journal:  J Ovarian Res       Date:  2016-12-07       Impact factor: 4.234

Review 6.  Polycystic Ovary Syndrome and Periodontal disease: Underlying Links- A Review.

Authors:  Sri Chandana Tanguturi; Sreenivas Nagarakanti
Journal:  Indian J Endocrinol Metab       Date:  2018 Mar-Apr

7.  The biological variation of N-terminal pro-brain natriuretic peptide in postmenopausal women with type 2 diabetes: a case control study.

Authors:  Susana González; Eric S Kilpatrick; Stephen L Atkin
Journal:  PLoS One       Date:  2012-11-09       Impact factor: 3.240
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.